Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for ...
During a recent AJMC Peer Exchange, a panel of experts delved into the clinical characteristics and heterogeneity of desmoid tumors, the importance of a multidisciplinary approach in both ...
Desmoid tumors are noncancerous growths that appear in connective tissue, most often on the arms, legs, and abdomen. Aggressive tumors must be treated with surgery, radiation, or chemotherapy to keep ...
Credit: SpringWorks. Nirogacestat is an oral, selective, small molecule gamma secretase inhibitor. Treatment with Ogsiveo significantly reduced the risk of disease progression by 71% compared with ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by SpringWorks Therapeutics for Ogsiveo ™ (nirogacestat).
The Food and Drug Administration on Monday approved the first treatment for people with desmoid tumors, a localized cancer that invades soft tissue and muscle. The new drug, called Ogsiveo, is made by ...
LEXINGTON, Ky. (LEX 18) — Diagnosed with a rare condition at age 18, Mackenzie Wilmoth has recovered, and she's leading the efforts to help those dealing with Pediatric Cancer. Wilmoth was in a ...
STAMFORD, Conn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today ...
Desmoid tumours, also known as desmoid-type fibromatosis, represent a rare yet locally aggressive proliferation of fibroblasts. Despite their benign classification due to the lack of metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback